Featured news in The Life Sciences Report

ProMIS Neurosciences Inc. (PMN:TSX; PMN:NCM)
Announces CDN$3 Million Best-Efforts Private Placement (7/20/2017)
view
 


Resverlogix Corp. (RVX:TSX)
Today's Research Reports on GeneNews Limited, Centric Health Corporation, Resverlogix Corp. and TSO3 Inc. (7/26/2017)
view
 

Resverlogix Corp. (RVX:TSX)
Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017 (7/25/2017)
view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017 (7/26/2017)
view
 


Celgene Corp. (CELG:NASDAQ)
Amgen (AMGN) Stock Falls Despite Q2 Earnings & Sales Beat (7/26/2017)
view
 


Resverlogix Corp. (RVX:TSX)
CORRECTION FROM SOURCE: IIROC Trade Halt - Resverlogix Corp. (7/25/2017)
view
 

Resverlogix Corp. (RVX:TSX)
IIROC Trade Halt - Resverlogix Corp. (7/25/2017)
view
 

Resverlogix Corp. (RVX:TSX)
Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial (7/25/2017)
view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (7/25/2017)
view